TP53 and cancer: Likewise, p28 has been successfully employed to deliver chemotherapeutics such as doxorubicin, dacarbazine, temozolomide, paclitaxel, and docetaxel to human cancer cells expressing either wild-type or mutated p53, improving the therapeutic efficacy of these drugs and reducing the doses administered (84).